CLINICAL_TRIALS
trial_result
· 2025-03-17
Clinical Trial Update: A Study to Assess Tolerability, Safety, Pharmacokinetics and Effect of AZP2006 in Patients With PSP [Phase 2]
Summary
Phase 2 study evaluating tolerability, safety, pharmacokinetics and effect of AZP2006 in progressive supranuclear palsy has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: AlzProtect SAS | Conditions: Progressive Supranuclear Palsy | Phase 2 | Status: COMPLETED